3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Polycythemia Vera
3
Venous Thromboembolism
2
Thrombocythemia, Essential
2
Rectal Neoplasms
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Adenoma
2
Vascular Diseases
1
Thrombosis
1
Thrombocytopenia
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Pathologic Processes
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Lymphoma, Follicular
1
Liver Cirrhosis
1
Ischemic Stroke
1
Interventions
Zoledronic Acid
4
Denosumab
4
Toremifene
2
Vitamin D
1
Cholecalciferol
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Fractures, Bone
×
Aspirin
×
Clear all
NCT01646437
2021-09-16
TIPS-3
Population Health Research Institute
Phase 3
Completed
7,793 enrolled